Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Patrizia DELLA VALLE"'
Autor:
Andrea Annoni, Alessio Cantore, Patrizia Della Valle, Kevin Goudy, Mahzad Akbarpour, Fabio Russo, Sara Bartolaccini, Armando D'Angelo, Maria Grazia Roncarolo, Luigi Naldini
Publikováno v:
EMBO Molecular Medicine, Vol 5, Iss 11, Pp 1684-1697 (2013)
Abstract A major complication of factor replacement therapy for haemophilia is the development of anti‐factor neutralizing antibodies (inhibitors). Here we show that liver gene therapy by lentiviral vectors (LVs) expressing factor IX (FIX) strongly
Externí odkaz:
https://doaj.org/article/ebac0ce6ddd046b0865fecd8245a9d7e
Autor:
Giorgia Serena Gullotta, Donatella De Feo, Ekaterina Friebel, Aurora Semerano, Giulia Maria Scotti, Andrea Bergamaschi, Erica Butti, Elena Brambilla, Angela Genchi, Alessia Capotondo, Mattia Gallizioli, Simona Coviello, Marco Piccoli, Tiziana Vigo, Patrizia Della Valle, Paola Ronchi, Giancarlo Comi, Armando D’Angelo, Norma Maugeri, Luisa Roveri, Antonio Uccelli, Burkhard Becher, Gianvito Martino, Marco Bacigaluppi
Publikováno v:
Nature Immunology. 24:925-940
Autor:
Marta Brambilla, Paola Canzano, Patrizia Della Valle, Alessia Becchetti, Maria Conti, Mariangela Alberti, Arianna Galotta, Maria Luisa Biondi, Paola Adele Lonati, Fabrizio Veglia, Alice Bonomi, Nicola Cosentino, Pier Luigi Meroni, Gian Vincenzo Zuccotti, Armando D'Angelo, Marina Camera
Publikováno v:
Thrombosis Research. 223:24-33
Autor:
Filippo CONSOLO, Patrizia DELLA VALLE, Marco SARACINO, Marta BONORA, Giovanni DONADONI, Fabio CICERI, Moreno TRESOLDI, Armando D’ANGELO, Giovanni LANDONI, Alberto ZANGRILLO
Publikováno v:
Minerva anestesiologica. 88(6)
Background: Platelet activation at the early stage of COVID-19 is poorly described. The need for antiplatelet therapy in patients with COVID-19 remains controversial. We characterized the platelet activation profile in hospitalized patients at the ea
Autor:
Marina Pieri, Alberto Redaelli, Armando D'Angelo, Filippo Consolo, Anna Mara Scandroglio, Patrizia Della Valle, Federico Pappalardo, Alessandra Marasi, Marta Bonora, Alberto Zangrillo
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 62
OBJECTIVES To evaluate the competing pro-haemorrhagic contribution of acquired von Willebrand (vW) disease and antithrombotic therapy in patients implanted with continuous-flow left ventricular assist devices (LVADs). METHODS We compared the extent o
Autor:
Patrizia Della Valle, Rosalba Lembo, Loris Pozzi, Giulia Motolone, Alberto Redaelli, Marvin J. Slepian, Federico Pappalardo, Lorenzo Valerio, Michele De Bonis, Alberto Zangrillo, Giulia Sferrazza, Filippo Consolo, Rachele Contri, Gianfranco Beniamino Fiore
Publikováno v:
European Journal of Heart Failure. 20:792-800
Aims To correlate the dynamics of platelet activation with the development of thromboembolic events in patients with continuous-flow left ventricular assist device (cf-LVAD). Methods and results The platelet activity state (PAS) assay was utilized to
Autor:
Giovanna D'Andrea, Rosa Santacroce, Armando D'Angelo, S. Viganò, Patrizia Della Valle, Maurizio Margaglione
Publikováno v:
Thrombosis Research. 166:60-62
Autor:
Matteo Pecchiari, Patrizia Della Valle, Edgardo D'Angelo, Antonia Koutsoukou, Guendalina Gentile
Publikováno v:
Respiratory physiologyneurobiology. 274
Sixty-three, open-chest normal rats were subjected to mechanical ventilation (MV) with tidal volumes (VT) ranging from 7.5–39.5ml kg−1 and PEEP 2.3 cmH2O. Arterial blood gasses and pressure, and lung mechanics were measured during baseline ventil
Autor:
Marco Spinelli, Chiara Brombin, Nufar Marcus, Dario Di Silvestre, Patrizia Della Valle, Lucia Piceni Sereni, Maria Ester Bernardo, Pierluigi Mauri, Francesca Ferrua, Claudio Pignata, Lorella Cattaneo, Alessandro Aiuti, Lucia Dora Notarangelo, Armando D'Angelo, Marita Bosticardo, Stefania Giannelli, Koen van Rossem, Maddalena Migliavacca, Anna Villa, Loris Pozzi, Roula Farah, Maria Carmina Castiello, Maria Pia Cicalese
Publikováno v:
Journal of allergy and clinical immunology 144 (2019): 825–838. doi:10.1016/j.jaci.2019.03.012
info:cnr-pdr/source/autori:Sereni L1, Castiello MC1, Di Silvestre D2, Della Valle P3, Brombin C4, Ferrua F5, Cicalese MP6, Pozzi L3, Migliavacca M6, Bernardo ME6, Pignata C7, Farah R8, Notarangelo LD9, Marcus N10, Cattaneo L11, Spinelli M12, Giannelli S1, Bosticardo M1, van Rossem K13, D'Angelo A3, Aiuti A5, Mauri P2, Villa A14./titolo:Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome/doi:10.1016%2Fj.jaci.2019.03.012/rivista:Journal of allergy and clinical immunology/anno:2019/pagina_da:825/pagina_a:838/intervallo_pagine:825–838/volume:144
The Journal of Allergy and Clinical Immunology
info:cnr-pdr/source/autori:Sereni L1, Castiello MC1, Di Silvestre D2, Della Valle P3, Brombin C4, Ferrua F5, Cicalese MP6, Pozzi L3, Migliavacca M6, Bernardo ME6, Pignata C7, Farah R8, Notarangelo LD9, Marcus N10, Cattaneo L11, Spinelli M12, Giannelli S1, Bosticardo M1, van Rossem K13, D'Angelo A3, Aiuti A5, Mauri P2, Villa A14./titolo:Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome/doi:10.1016%2Fj.jaci.2019.03.012/rivista:Journal of allergy and clinical immunology/anno:2019/pagina_da:825/pagina_a:838/intervallo_pagine:825–838/volume:144
The Journal of Allergy and Clinical Immunology
BACKGROUND: Thrombocytopenia is a serious issue for all patients with classical Wiskott-Aldrich syndrome (WAS) and X-linked thrombocytopenia (XLT) because it causes severe and life-threatening bleeding. Lentiviral gene therapy (GT) for WAS has shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fbef2a3b9359481a3aee0ecf5da45bb
https://publications.cnr.it/doc/417797
https://publications.cnr.it/doc/417797
Autor:
Armando D'Angelo, Francesco Violi, Patrizia Della Valle, Gloria Taliani, Camilla Calvieri, Roberto Cangemi, Roberto Carnevale, Patrizia Ferroni, Marco Falcone, Simona Bartimoccia
Publikováno v:
Respirology. 21:1465-1471
Background and objective Community-acquired pneumonia (CAP) is associated with an increased risk of arterial and venous thrombosis but the underlying pathophysiological mechanisms are still unclear. We investigated if, in patients with CAP, a pro-thr